We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-11.69%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.96B
AUM Growth
-$276M
Cap. Flow
+$2.54M
Cap. Flow %
0.13%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$2.64M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$91.7K

Sector Composition

Rank Sector Weight
1 Healthcare 64.43%
2 Consumer Staples 21.09%
3 Miscellaneous 7.7%
4 Industrials 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$1.11B 56.77%
8,663,584
-655
-0% -$91.7K
MNST icon
2
Monster Beverage
MNST
$87.7B
$414M 21.09%
18,625,952
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$151M 7.7%
690,000
– –
AXON
4
Axon Enterprise
AXON
$38.4B
$133M 6.78%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$266M
$85.7M 4.37%
34,005,379
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$125M
$61.8M 3.15%
867,497
+28,673
+3% +$2.64M
SER icon
7
Serina Therapeutics
SER
$58.2M
$2.82M 0.14%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Broadwood Capital held 7 positions worth $1.96B, down 12% from $2.24B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 68% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q3 2021, an estimated $2.64M increase.
  • Broadwood Capital's biggest Q3 2021 reduction was STAAR Surgical, cutting an estimated $91.7K.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.96B portfolio in Q3 2021.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2021.
  • Broadwood Capital's portfolio value fell 12% quarter-over-quarter to $1.96B.

Based on Broadwood Capital's 13F filing for Q3 2021, filed 15 Nov 2021.